COVID-19 Vaccine-Induced Pneumonitis, Myositis and Myopericarditis

A 63-year-old male, with no significant past history and not on any regular medications previously, had mild respiratory symptoms post the first dose of the AstraZeneca (Cambridge, England) coronavirus disease 2019 (COVID-19) vaccine, which were self-limiting. Following the second dose of the vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Farooq, Mariya, Mohammed, Yaser, Zafar, Mansoor, Dharmasena, Dawpadee, Rana, Usman Iqbal, Kankam, Osei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733846/
https://www.ncbi.nlm.nih.gov/pubmed/35004093
http://dx.doi.org/10.7759/cureus.20979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733846/
https://www.ncbi.nlm.nih.gov/pubmed/35004093
http://dx.doi.org/10.7759/cureus.20979

Ejemplares similares